METHODS: We performed integrative transcriptome analyses of pediatric AML datasets (TARGET-AML, GSE246783: MI3454; GSE292324: PRMT5 inhibition; GSE292050: NID1 knockdown) and incorporated adult AML data from TCGA and GTEx. This evidence concerns the gene NID1 and acute myeloid leukemia.